ACCURAY INC ARAY

Latest FY: 2025 Healthcare Medical Devices
Market Price $0.28
Market Cap $33.31M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑2.7% YoY
$458.50M
3-Yr CAGR: 2.2%
Net Income ↑89.8% YoY
-$1.59M
Net Margin: -0.3%
Free Cash Flow ↑90.9% YoY
-$1.41M
FCF Yield: -4.24%
EPS (Diluted) ↑87.5% YoY
$-0.02
Basic: $-0.02
Return on Equity Efficiency
-2.0%
ROA: -4.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ARAY)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $398.8M $158.7M $-25.5M $33.5M $25.5M
FY 2017 $383.4M -3.9% $141.3M $-29.6M -16.0% $-0.36 $-0.4M $-5.4M -121.2%
FY 2018 $404.9M +5.6% $161.7M $-23.9M +19.2% $-0.28 +22.2% $18.3M $12.1M +322.8%
FY 2019 $418.8M +3.4% $162.7M $-16.4M +31.3% $-0.19 +32.1% $-29.6M $-34.0M -381.6%
FY 2020 $382.9M -8.6% $149.7M $3.8M +123.3% $0.04 +121.1% $-1.5M $-5.0M +85.2%
FY 2021 $396.3M +3.5% $159.5M $-6.3M -264.9% $-0.07 -275.0% $38.5M $36.2M +820.0%
FY 2022 $429.9M +8.5% $160.0M $-5.3M +15.3% $-0.06 +14.3% $-2.4M $-7.1M -119.7%
FY 2023 $447.6M +4.1% $154.0M $-9.3M -73.6% $-0.10 -66.7% $15.5M $2.9M +141.1%
FY 2024 $446.6M -0.2% $142.9M $-15.5M -67.5% $-0.16 -60.0% $-11.9M $-15.5M -630.1%
FY 2025 $458.5M +2.7% $147.0M $-1.6M +89.8% $-0.02 +87.5% $2.9M $-1.4M +90.9%
$

Valuation

Market Price $0.28
Market Cap $33.31M
Enterprise Value $112.41M
P/E Ratio N/A
P/B Ratio 0.41
FCF Yield -4.24%
Dividend Yield N/A
Shares Outstanding 118,963,700
%

Profitability & Margins

Gross Margin 32.05%
Operating Margin 1.71%
Net Margin -0.35%
Return on Equity (ROE) -1.96%
Return on Assets (ROA) -4.75%
Asset Turnover 13.69x
Revenue 3-Yr CAGR 2.17%
🛡️

Financial Health & Liquidity

Current Ratio 0.17
Cash Ratio 0.30
Debt / Equity 1.682
Debt / Assets 4.075
Cash & Equivalents $57.42M
Total Debt $136.52M
Book Value / Share $0.68
💧

Cash Flow Efficiency

Operating Cash Flow $2.86M
Capital Expenditures (CapEx) $4.27M
Free Cash Flow -$1.41M
OCF / Revenue 0.62%
FCF / Revenue -0.31%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.02
EPS (Basic) $-0.02
Dividends / Share N/A
Book Value / Share $0.68
EPS YoY Growth 87.50%
🏛️

Balance Sheet (FY 2025)

Total Assets $33.50M
Total Liabilities $192.58M
Stockholders' Equity $81.17M
Current Assets $33.50M
Current Liabilities $192.58M